Literature DB >> 31070482

LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21.

Wei Liu1.   

Abstract

Background: Downregulation of LncRNA LINC-PINT has been observed in different types of cancer cells, indicating its role as a tumor suppressor. Materials and
Methods: Expression of LINC-PINT and miRNA-21 in tumor tissues and adjacent healthy tissues of 56 patients with osteosarcoma was detected by real-time quantitative PCR. Correlations between expression levels of LncRNA LINC-PINT and miRNA-21 were analyzed by Pearson's correlation coefficient.
Results: In this study, we found that LncRNA LINC-PINT was inhibited, whereas miRNA-21 was promoted in tumor tissues than in adjacent healthy tissues of patients with osteosarcoma. Expression levels of LncRNA LINC-PINT were affected by both tumor size and tumor metastasis. LncRNA LINC-PINT and miRNA-21 were significantly and reversely correlated in both tumor cells and adjacent healthy tissues. LncRNA LINC-PINT overexpression led to downregulated miRNA-21 expression in cancer cells, whereas miRNA-21 overexpression did not significantly affect LINC-PINT expression. Overexpression of LncRNA LINC-PINT inhibited whereas miRNA-21 overexpression promoted cancer cell proliferation, migration, and invasion. In addition, miRNA-21 overexpression partially rescued the inhibited cell proliferation, migration, and invasion mediated by LncRNA LINC-PINT overexpression.
Conclusion: Therefore, LncRNA LINC-PINT may inhibit cancer cell proliferation, invasion, and migration in osteosarcoma by downregulating miRNA-21.

Entities:  

Keywords:  LncRNA LINC-PINT; miRNA-21; osteosarcoma

Mesh:

Substances:

Year:  2019        PMID: 31070482     DOI: 10.1089/cbr.2018.2684

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  9 in total

1.  LncRNA FTX inhibition restrains osteosarcoma proliferation and migration via modulating miR-320a/TXNRD1.

Authors:  Shuaihao Huang; Xiaowen Zhu; Yuhong Ke; Dan Xiao; Changxiang Liang; Junfeng Chen; Yunbing Chang
Journal:  Cancer Biol Ther       Date:  2020-01-10       Impact factor: 4.742

2.  TMPO-AS1 promotes cell proliferation of thyroid cancer via sponging miR-498 to modulate TMPO.

Authors:  Zhenyu Li; Yun Feng; Zhen Zhang; Xiaozhong Cao; Xiubo Lu
Journal:  Cancer Cell Int       Date:  2020-07-08       Impact factor: 5.722

3.  LINC-PINT impedes DNA repair and enhances radiotherapeutic response by targeting DNA-PKcs in nasopharyngeal cancer.

Authors:  You-Hong Wang; Zhen Guo; Liang An; Yong Zhou; Heng Xu; Jing Xiong; Zhao-Qian Liu; Xiao-Ping Chen; Hong-Hao Zhou; Xiong Li; Tao Liu; Wei-Hua Huang; Wei Zhang
Journal:  Cell Death Dis       Date:  2021-05-07       Impact factor: 8.469

4.  A long non-coding RNA LINC00461-dependent mechanism underlying breast cancer invasion and migration via the miR-144-3p/KPNA2 axis.

Authors:  Qiang Zhang; Xiaoyan Jin; Wenbiao Shi; Xin Chen; Wenyang Pang; Xiaodong Yu; Linjun Yang
Journal:  Cancer Cell Int       Date:  2020-04-26       Impact factor: 5.722

5.  Downregulation of long non-coding RNA LINC-PINT serves as a diagnostic and prognostic biomarker in patients with non-small cell lung cancer.

Authors:  Chunjie Zhang; Cuixue Gong; Jianzhao Li; Jiaying Tang
Journal:  Oncol Lett       Date:  2021-01-18       Impact factor: 2.967

6.  Long intergenic noncoding RNA smad7 (Linc-smad7) promotes the epithelial-mesenchymal transition of HCC by targeting the miR-125b/SIRT6 axis.

Authors:  Lili Han; Lijun Jia; Ying Zan
Journal:  Cancer Med       Date:  2020-10-10       Impact factor: 4.452

Review 7.  Emerging Advances of Non-coding RNAs and Competitive Endogenous RNA Regulatory Networks in Asthma.

Authors:  Xiaoxu Wang; Hui Chen; Jingjing Liu; Linlin Gai; Xinyi Yan; Zhiliang Guo; Fengxia Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer.

Authors:  Jeyshka M Reyes-González; Blanca I Quiñones-Díaz; Yasmarie Santana; Perla M Báez-Vega; Daniel Soto; Fatima Valiyeva; María J Marcos-Martínez; Ricardo J Fernández-de Thomas; Pablo E Vivas-Mejía
Journal:  Cancers (Basel)       Date:  2020-04-04       Impact factor: 6.639

9.  CircPDZD8 promotes gastric cancer progression by regulating CHD9 via sponging miR-197-5p.

Authors:  Tianfang Xia; Zhenguo Pan; Jie Zhang
Journal:  Aging (Albany NY)       Date:  2020-10-13       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.